TRX-818 is a new, potent and multi-targeted anti-cancer agent in numerous human cancer cell lines. A phase I safety and pharmacokinetic study of TRX-818 administered orally to patients with advanced cancer.
For research and scientific purpose only, not for human use!
没有评论:
发表评论